InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: loanranger post# 292841

Friday, 04/17/2020 9:23:09 AM

Friday, April 17, 2020 9:23:09 AM

Post# of 402880
Here is what was said about the drug: “ The early signs come from a small study of just 125 infected patients at a Chicago hospital, part of a broader trial for the Gilead Science drug. Of those patients, 113 had severe complications, STAT News reported. Most of the patients have been discharged, although two people died, according to STAT News.” https://www.washingtonpost.com/world/2020/04/17/coronavirus-latest-news/#link-JHB4BKUBLNHRLNTBGOPPZBFJWU

125 patients, 2 died. Isn’t that (~2%) the mortality rate for patients with symptoms? Other issues, we don’t know the selection criteria for the study. The report doesn’t state a control or comparison group. Was there a control? This Gilead study has all the earmarks and flags that those hydroxychloroquine studies have.

* Never borrow to invest.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News